Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 16, 2020

SELL
$57.43 - $63.64 $248,269 - $275,115
-4,323 Closed
0 $0
Q2 2020

Jul 21, 2020

SELL
$54.82 - $64.09 $59,644 - $69,729
-1,088 Reduced 20.11%
4,323 $254,000
Q1 2020

Apr 28, 2020

SELL
$46.4 - $67.43 $21,019 - $30,545
-453 Reduced 7.73%
5,411 $302,000
Q4 2019

Jan 07, 2020

BUY
$49.21 - $64.19 $69,090 - $90,122
1,404 Added 31.48%
5,864 $376,000
Q3 2019

Oct 17, 2019

BUY
$42.77 - $50.71 $598 - $709
14 Added 0.31%
4,460 $226,000
Q2 2019

Jul 10, 2019

BUY
$44.62 - $49.34 $198,380 - $219,365
4,446 New
4,446 $202,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Leonard Rickey Investment Advisors P.L.L.C. Portfolio

Follow Leonard Rickey Investment Advisors P.L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leonard Rickey Investment Advisors P.L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Leonard Rickey Investment Advisors P.L.L.C. with notifications on news.